The effect and mechanism of Glucagon-like peptide-1 protects against the diabetic cardiomyopathy

被引：0
|
作者：
Wu, Qinan [1 ]
Lei, Xiaotian [1 ]
Gan, Xiaguang [1 ]
Deng, Wuquan [1 ]
Chen, Bing [1 ]
Liang, Ziwen [1 ]
Liang, Ziwen [1 ]
机构：
[1] Third Mil Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2015年 / 66卷 / 16期
关键词：
D O I：
10.1016/j.jacc.2015.06.378
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
GW26-e0013
引用
收藏
页码：C97 / C97
页数：1
相关论文
共 50 条
  • [1] Glucagon-Like Peptide-1 Analog Liraglutide Protects against Diabetic Cardiomyopathy by the Inhibition of the Endoplasmic Reticulum Stress Pathway
    Liu, Jieyu
    Liu, Yu
    Chen, Li
    Wang, Yuehui
    Li, Junqi
    JOURNAL OF DIABETES RESEARCH, 2013, 2013
  • [2] EFFECT OF GLUCAGON ON SECRETION OF GLUCAGON-LIKE PEPTIDE-1
    SHIMA, K
    OHBOSHI, C
    SATO, M
    HIROTA, M
    HORMONE AND METABOLIC RESEARCH, 1988, 20 (02) : 123 - 124
  • [3] Glucagon and glucagon-like peptide-1
    Livingston, JN
    Schoen, WR
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 34, 1999, 34 : 189 - 198
  • [4] Glucagon-like peptide-1
    Doyle, ME
    Egan, JM
    RECENT PROGRESS IN HORMONE RESEARCH, VOL 56, 2001, 56 : 377 - 399
  • [5] A hypothesis: Glucagon-like peptide-1 may play a protective role in diabetic cardiomyopathy
    Fan, Zhixing
    Yang, Chaojun
    Yang, Jian
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 197 : 294 - 295
  • [6] Glucagon-like peptide-1 and glucagon-like peptide-2
    Baggio, LL
    Drucker, DJ
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 18 (04) : 531 - 554
  • [7] Glucagon-Like Peptide-1 Protects Against Atrial Fibrillation and Atrial Remodeling in Type 2 Diabetic Mice
    Bohne, Loryn J.
    Jansen, Hailey J.
    Dorey, Tristan W.
    Daniel, Irene M.
    Jamieson, K. Lockhart
    Belke, Darrell D.
    Mcrae, Megan D.
    Rose, Robert A.
    JACC-BASIC TO TRANSLATIONAL SCIENCE, 2023, 8 (08): : 922 - 936
  • [8] The receptor mechanism involved in neuroincretin effect of glucagon-like peptide-1
    Nishizawa, M
    Nakabayashi, H
    Uchida, K
    Niijima, A
    DIABETOLOGIA, 1997, 40 : 494 - 494
  • [9] Glucagon-Like Peptide-1 Receptor Agonist Protects Against Diabetic Cardiomyopathy by Modulating microRNA-29b-3p/SLMAP
    Fang, Ping
    Ye, Zhengqin
    Li, Ran
    She, Dunmin
    Zong, Guannan
    Zhang, Liya
    Xue, Ying
    Zhang, Keqin
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2023, 17 : 791 - 806
  • [10] Protective effect of glucagon-like peptide-1 mediated by ultrasound microbubbles on myocardial injury in rats with diabetic cardiomyopathy
    Liu, Yanjie
    Chen, Li
    Wu, Hao
    Zhang, Hebin
    BIOENGINEERED, 2022, 13 (02) : 3251 - 3261
12345